v1
Phase 2, randomized, dose-ranging study evaluating the safety and efficacy of anidulafungin in invasive candidiasis and candidemia.
Identifier:nobleid.org/w1/20260515/B7AFACB8
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/B7AFACB8)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →